Lp‑PLA2、sdLDL及Hcy对冠心病及严重程度的评估价值

岳晓乐; 李薇薇; 赵丹丹; 李宛秋; 王思羽; 张颖; 纪昕

doi:10.14188/j.1671-8852.2024.0058

您当前的位置：

首页 >

文章列表页 >

Lp‑PLA2、sdLDL及Hcy对冠心病及严重程度的评估价值

临床医学研究 | 更新时间：2026-11-05

- Lp‑PLA2、sdLDL及Hcy对冠心病及严重程度的评估价值
- Risk assessment value of Lp‑PLA2, sdLDL and Hcy in coronary heart disease and its severity
- 武汉大学学报（医学版） 2025年46卷第7期页码：890-894
- 作者机构：
  
  1.河北医科大学第二医院检验科河北石家庄 050000
  2.南方科技大学医院检验科广东深圳 518055
- 作者简介：
  
  岳晓乐，女，1986—，医学硕士，主管检验师，主要从事临床生物化学检验研究，E‑mail：yuexiaole2022@163.com
  纪昕，男，1980—，医学博士，副主任检验师，副教授，硕士生导师，主要从事临床生物化学检验研究，E‑mail：jixin1001@163.com
- 基金信息：
  
  2021年度河北省医学科学研究课题计划(20211498)
- DOI：10.14188/j.1671-8852.2024.0058
  中图分类号： R541.4
- 收稿：2024-01-22，
  
  纸质出版：2025-07-25
- 稿件说明：
移动端阅览
岳晓乐,李薇薇,赵丹丹等.Lp‑PLA2、sdLDL及Hcy对冠心病及严重程度的评估价值[J].武汉大学学报（医学版）,2025,46(07):890-894.

YUE Xiaole,LI Weiwei,ZHAO Dandan,et al.Risk assessment value of Lp‑PLA2, sdLDL and Hcy in coronary heart disease and its severity[J].Medical Journal of Wuhan University,2025,46(07):890-894.
岳晓乐,李薇薇,赵丹丹等.Lp‑PLA2、sdLDL及Hcy对冠心病及严重程度的评估价值[J].武汉大学学报（医学版）,2025,46(07):890-894. DOI： 10.14188/j.1671-8852.2024.0058.

YUE Xiaole,LI Weiwei,ZHAO Dandan,et al.Risk assessment value of Lp‑PLA2, sdLDL and Hcy in coronary heart disease and its severity[J].Medical Journal of Wuhan University,2025,46(07):890-894. DOI： 10.14188/j.1671-8852.2024.0058.

摘要

目的

研究脂蛋白相关磷脂酶A2(Lp‑PLA2)、小而密低密度脂蛋白(sdLDL)及同型半胱氨酸(Hcy)对冠心病(CHD)及严重程度的联合风险评估。

方法

回顾性选择2020年12月—2022年6月在河北医科大学第二医院进行冠状动脉（冠脉）造影检查的195例患者作为研究对象，将符合CHD诊断标准的121例患者作为CHD组，不符合CHD诊断标准的74例患者作为对照组。比较两组患者及CHD不同严重程度患者血清Lp‑PLA2、sdLDL及Hcy，采用受试者工作特征曲线(ROC)分析指标对CHD及严重程度的诊断。

结果

CHD组血清Lp‑PLA2、sdLDL及Hcy均高于对照组(均

0.05)，且血清Lp‑PLA2、sdLDL及Hcy对CHD有诊断价值(均

0.05)；与单一指标比，Lp‑PLA2、sdLDL、Hcy联合检测对CHD诊断效能更高，曲线下面积(

AUC

)和特异性均较高。CHD组单支与多支病变血清Lp‑PLA2、sdLDL及Hcy差异无统计意义(均

0.05)，CHD组冠脉重度病变血清Lp‑PLA2、sdLDL及Hcy均高于轻度病变(均

0.05)，且血清Lp‑PLA2、sdLDL及Hcy水平对CHD严重程度有诊断价值(

0.05)；与单一指标比，Lp‑PLA2、sdLDL、Hcy联合检测对CHD严重程度的诊断效能更高，

AUC

和灵敏度均较高。

结论

CHD患者血清Lp‑PLA2、sdLDL及Hcy明显升高，Lp‑PLA2、sdLDL、Hcy联合检测对CHD及严重程度均有诊断价值，三者联合检测或可成为筛查CHD及诊断CHD严重程度的潜在指标。

Abstract

Objective

To study the risk assessment value of lipoprotein‑associated phospholipase A2(Lp‑PLA2)

small dense low‑density lipoprotein (sdLDL) and homocysteine (Hcy) in coronary heart disease(CHD) and its severity.

Methods

A total of 195 patients who underwent coronary angiography in The Second Hospital of Hebei Medical University from December 2020 to June 2022 were selected

including 121 patients who met the diagnostic criteria of CHD (CHD group) and 74 patients who did not meet the diagnostic criteria of CHD (control group). The serum Lp‑PLA2

sdLDL

and Hcy between the two groups

as well as CHD patients with different severity were compared. The receiver operating characteristic (ROC) was used to analyze the diagnostic value of serum indicators for CHD and its severity.

Results

The ser

um Lp‑PLA2

sdLDL and Hcy in the CHD group were higher than those in the control group (

0.05)

and the serum Lp‑PLA2

sdLDL and Hcy had diagnostic value for CHD (

0.05). Compared with a single indicator

Lp‑PLA2+sdLDL+Hcy detection had a higher diagnostic value for CHD

with a higher area under the curve (

AUC

) and specificity. There was no difference in Lp‑PLA2

sdLDL

and Hcy between single and multi⁃vessel lesion(s) subgroups in the CHD group (

0.05). The Lp‑PLA2

sdLDL and Hcy in patients with severe CHD were higher than those in mild CHD (

0.05). The Lp‑PLA2

sdLDL and Hcy had diagnostic value for the severity of CHD (

0.05). Compared with a single indicator

Lp‑PLA2+sdLDL+Hcy detection had a higher diagnostic value for the severity of CHD

with higher

AUC

and sensitivity.

Conclusion

The serum Lp‑PLA2

sdLDL and Hcy in CHD patients are elevated. The Lp‑PLA2+sdLDL+Hcy detection has diagnostic value for CHD and its severity. The Lp‑PLA2+sdLDL+Hcy detection may become a potential indicator for screening and differential diagnosis of CHD and its severity.

关键词

Keywords

references

RALAPANAWA U , SIVAKANESAN R . Epidemiology and the magnitude of coronary artery disease and acute coronary syndrome: A narrative review [J ] . J Epidemiol Glob Health , 2021 , 11 ( 2 ): 169 ‑ 177 .

ZHANG H , GAO Y , WU D , et al . The relationship of lipoprotein‑associated phospholipase A2 activity with the seriousness of coronary artery disease [J ] . BMC Cardiovasc Disord , 2020 , 20 ( 1 ): 295 .

苏保满 , 杨琳梅 , 叶中倪 . sdLDL‑C和LDL‑C水平与冠状动脉粥样硬化病变程度的相关性分析 [J ] . 武警后勤学院学报(医学版) , 2020 , 29 ( 5 ): 28 ‑ 31 .

SU B M , YANG L M , YE Z N . Correlation between the levels of sdLDL‑C and LDL‑C and degree of coronary atherosclerosis lesions [J ] . J Logist Univ PAP Med Sci , 2020 , 29 ( 5 ): 28 ‑ 31 .

沈文生 , 周艳 , 齐英斌 , 等 . 血浆同型半胱氨酸水平与颈动脉粥样硬化的相关性 [J ] . 中国老年学杂志 , 2022 , 42 ( 3 ): 526 ‑ 529 .

SHEN W S , ZHOU Y , QI Y B , et al . Correlation between plasma homocysteine levels and carotid atherosclerosis [J ] . Chin J Gerontol , 2022 , 42 ( 3 ): 526 ‑ 529 .

中华医学会心血管病学分会介入心脏病学组 , 中华医学会心血管病学分会动脉粥样硬化与冠心病学组 . 稳定性冠心病诊断与治疗指南 [J ] . 中华心血管病杂志 , 2018 , 46 ( 9 ): 680 ‑ 694 .

Interventional Cardiology Group , Cardiovascular Branch , Chinese Medical Association ; Atherosclerosis and Coronary Heart Disease Group , Cardiovascular Branch , Chinese Medical Association . Guidelines for the diagnosis and treatment of stable coronary heart disease [J ] Chinese J Cardiovasc Dis , 2018 , 46 ( 9 ): 680 ‑ 694 .

ZEITOUNI M , CLARE R M , CHISWELL K , et al . Risk factor burden and long‑term prognosis of patients with premature coronary artery disease [J ] . J Am Heart Assoc , 2020 , 9 ( 24 ): e017712 .

HO Y L , NGUYEN X M T , YAN J Q , et al . Chocolate consumption and risk of coronary artery disease: The Million Veteran Program [J ] . Am J Clin Nutr , 2021 , 113 ( 5 ): 1137 ‑ 1144 .

ZHANG J , ZHANG Q , ZHAO K et al . Risk factors for in‑stent restenosis after coronary stent implantation in patients with coronary artery disease: A retrospective observational study [J ] . Medicine , 2022 , 101 ( 47 ): e31707 .

蒋洋波 , 王权 , 季敏 , 等 . 血清可溶性CD40配体、脂蛋白相关的磷脂酶A2水平与老年急性脑梗死的相关性 [J ] . 武汉大学学报(医学版) , 2022 , 43 ( 3 ): 475 ‑ 479 .

JIANG Y B , WANG Q , JI M , et al . Correlation between serum levels of soluble CD40 ligand and lipoprotein‑associated phospholipase A2 in elderly patients with acute cerebral infarction [J ] . Med J Wuhan Univ , 2022 , 43 ( 3 ): 475 ‑ 479 .

朱竞 , 王舒 , 游莉 . 血清sdLDL‑C对冠心病PCI手术患者病情与预后评估的临床价值 [J ] . 武汉大学学报(医学版) , 2021 , 42 ( 6 ): 1012 ‑ 1015 .

ZHU J , WANG S , YOU L . Clinical value of serum sdLDL‑C in evaluating the condition and prognosis of patients with coronary heart disease undergoing PCI [J ] . Med J Wuhan Univ , 2021 , 42 ( 6 ): 1012 ‑ 1015 .

WANG L Y , ZHOU L L , WANG L H , et al . The diagnostic value of echocardiography combined with serum Hcy and PCSK9 in coronary heart disease [J ] . Biotechnol Genet Eng Rev , 2024 , 40 ( 3 ): 1884 ⁃ 1893 .

陈桂金 , 万友利 . 小而密低密度脂蛋白胆固醇与冠心病的相关性分析 [J ] . 国际检验医学杂志 , 2021 , 42 ( 16 ): 1925 ‑ 1928 .

CHEN G J , WAN Y L . Analysis of the correlation between small and dense low density lipoprotein cholesterol and coronary heart disease [J ] . Int J Lab Med , 2021 , 42 ( 16 ): 1925 ‑ 1928 .

李凤 , 陈静丹 , 薛桂君 . 老年冠心病合并高血压患者血清NO、Lp‑PLA2、Hcy水平与颈动脉粥样硬化程度的关系 [J ] . 标记免疫分析与临床 , 2019 , 26 ( 2 ): 185 ‑ 188 .

LI F , CHEN J D , XUE G J . Relationship between levels of serum NO, Lp‑PLA2, Hcy and the degree of carotid atherosclerosis in elderly patients with coronary heart disease complicated with hypertension [J ] . Labeled Immunoass Clin Med , 2019 , 26 ( 2 ): 185 ‑ 188 .

BRYNIARSKI K L , WANG Z , FRACASSI F , et al . Three‑dimensional fibrous cap structure of coronary lipid plaque ‑ ST‑elevation myocardial infarction vs stable angina [J ] . Circ J , 2019 , 83 ( 6 ): 1214 ‑ 1219 .

ARAKI M , SOEDA T , KIM H O , et al . Spatial distribution of vulnerable plaques: Comprehensive in vivo coronary plaque mapping [J ] . JACC Cardiovasc Imaging , 2020 , 13 ( 9 ): 1989 ‑ 1999 .

ZHANG L K , LI Z P , LI N . Serum IMA and LP‑PLA2 levels in patients with coronary heart disease and their correlation with the degree of myocardial ischaemia and their diagnostic value [J ] . Emerg Med Int , 2022 , 2022 : 1698315 .

GE P C , CHEN Z H , PAN R Y , et al . Synergistic effect of lipoprotein‑associated phospholipase A2 with classical risk factors on coronary heart disease: A multi‑ethnic study in China [J ] . Cell Physiol Biochem , 2016 , 40 ( 5 ): 953 ‑ 968 .

HUANG J , GU J X , BAO H Z , et al . Elevated serum small dense low‑density lipoprotein cholesterol may increase the risk and severity of coronary heart disease and predict cardiovascular events in patients with type 2 diabetes mellitus [J ] . Dis Markers , 2021 , 2021 : 5597028 .

GAO Y , GUO Y , HAO W , et al . Correlation analysis and diagnostic value of serum homocysteine, cystatin C and uric acid levels with the severity of coronary artery stenosis in patients with coronary heart disease [J ] . Int J Gen Med , 2023 , 16 ( 6 ): 2719 ‑ 2731 .

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

人工智能在晕厥诊治中的应用与前景

代谢相关性脂肪性肝病及多组学诊断研究进展

人工智能在乳腺癌中的应用

彩色多普勒超声及磁共振成像在胎盘植入诊断中的应用价值比较

核因子红细胞2相关因子2在缺血性脑卒中的机制和相关防治价值